Skip to content

Use of Lactate-to-Albumin, CRP-to-Albumin, and Procalcitonin-to-Albumin Ratios to Predict Mortality in ICU Patients

Lactate-to-albumin, CRP-to-albumin and Procalcitonin-to-albumin Ratios Predict Mortality in Critically Ill Adults: a Retrospective ICU Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07242027
Acronym
LAR-CAR-PAR
Enrollment
212
Registered
2025-11-21
Start date
2025-03-21
Completion date
2025-09-20
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Circulatory Failure, Critical Illness, Respiratory Failure, Sepsis, Sudden Cardiac Arrest

Keywords

LAR, CAR, PAR, ICU, mortality, prediction

Brief summary

This observational study aims to determine whether three blood test ratios - lactate-to-albumin, CRP-to-albumin, and procalcitonin-to-albumin - can predict in-hospital mortality among critically ill adults. The study includes all adult patients admitted in 2024 to the ICU Ward B at the Silesian Center for Heart Diseases (SCCS) in Zabrze. Researchers will analyze retrospective clinical and laboratory data from electronic medical records, including lab values collected at ICU admission, patient demographics, diagnoses, and outcomes. The biomarker ratios will be manually calculated in Excel and statistically evaluated. The main goal is to assess whether these ratios are associated with patient survival and to identify predictive cut-off values to support early risk stratification in the ICU setting.

Interventions

None listed

Sponsors

Medical University of Silesia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Admission to ICU in 2024 * Availability of data for lactate, CRP, procalcitonin, and albumin

Exclusion criteria

* Missing outcome data (e.g. unknown survival status) * Lack of laboratory parameters necessary for ratio calculation

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality100 days from the date of ICU admissionAll-cause in-hospital mortality among ICU patients during the index hospitalization.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026